Cargando…
Prevalence and utility of pharmacokinetic data in preclinical studies of mRNA cancer vaccines
In this brief report, we provide insights into current practices in preclinical messenger RNA (mRNA) cancer vaccine characterization. To enable a more automated and thorough survey of mRNA cancer vaccine data in the literature, we implemented natural language processing to mine abstracts from PubMed...
Autores principales: | Roth, Gillie A., Vora, Bianca, Kim, Chloe, Wu, Michael, Kuruvilla, Denison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499403/ https://www.ncbi.nlm.nih.gov/pubmed/37452560 http://dx.doi.org/10.1111/cts.13586 |
Ejemplares similares
-
Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020) -
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
por: Chavda, Vivek P., et al.
Publicado: (2022) -
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
por: Bähr-Mahmud, Hayat, et al.
Publicado: (2023) -
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
por: Kalnin, Kirill V., et al.
Publicado: (2021) -
Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
por: Qin, Jane, et al.
Publicado: (2023)